FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type
Clinical trial NCT02350530 · COMPLETED
Trial details
- NCT number
- NCT02350530
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2018-01-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.